KF-19514

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameKF-19514
Drug Alias NameKF19514
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 4 antagonistsPhosphodiesterase 1 inhibitors
TargetsPhosphodiesterase 1Fibroblast growth factor receptor 4
Therapy Area/IndicationsRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Hakko
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyowa Hakko
Active IndicationsN/A
Inactive IndicationsRhinitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A